AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia
Completed
- Conditions
- Bacterial Skin Diseases
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2013-06-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3000
- Registration Number
- NCT01700842
- Locations
- 🇷🇺
Research Site, Smolensk, Russian Federation
OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA
Completed
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependent
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2014-08-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 733
- Registration Number
- NCT01694758
- Locations
- 🇷🇴
Research Site, Timisoara, Romania
Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.
Phase 1
Completed
- Conditions
- Metastatic Castrate-Resistant Prostate Cancer (mCRPC),Efficacy,Safety and Tolerability,Pharmacokinetics,Pharmacodynamics,Tumour Response.
- Interventions
- Drug: Intermittent dosing of AZD5363
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 59
- Registration Number
- NCT01692262
- Locations
- 🇬🇧
Research Site, Southampton, United Kingdom
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
Completed
- Conditions
- SchizophreniaBipolar Episodes
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2015-12-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2292
- Registration Number
- NCT01689389
- Locations
- 🇫🇷
research Site, St Dizier, France
🇫🇷Research SIte, Obernai, France
🇫🇷Reserach Site, Cavaillon, France
Assess Pharmacokinetics of Fostamatinib in Fed and Fasted State in Combination With Ranitidine to Assess Bioavailability
Phase 1
Completed
- Conditions
- Pharmacokinetics
- Interventions
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2012-12-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 28
- Registration Number
- NCT01682408
Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients
Withdrawn
- Conditions
- Acute Coronary SyndromeAcute Myocardial Infarction
- First Posted Date
- 2012-09-05
- Last Posted Date
- 2012-10-03
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT01678339
- Locations
- 🇮🇹
Research Site, Palermo, Italy
Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)
Phase 3
Completed
- Conditions
- Refractory Reflux Esophagitis
- Interventions
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2015-08-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1398
- Registration Number
- NCT01669811
- Locations
- 🇯🇵
Research Site, Yufu-shi, Japan
A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD8683 When Administered in Different Ways
- First Posted Date
- 2012-08-16
- Last Posted Date
- 2012-12-19
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT01666613
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
Phase 1
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- First Posted Date
- 2012-08-14
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 40
- Registration Number
- NCT01664624
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
Terminated
- Conditions
- Bipolar DisorderSub-syndromal Symptoms
- First Posted Date
- 2012-08-14
- Last Posted Date
- 2015-03-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 125
- Registration Number
- NCT01663974
- Locations
- 🇫🇷
Research Site, Vincennes, France